Related Experiment Video
Updated: May 12, 2026

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
Published on: September 28, 2022
Fragments of the bacterial toxin microcin B17 as gyrase poisons
Frédéric Collin1, Robert E Thompson, Katrina A Jolliffe
1Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.
Abstract:
Fluoroquinolones are very important drugs in the clinical antibacterial arsenal; their success is principally due to their mode of action: the stabilisation of a gyrase-DNA intermediate (the cleavage complex), which triggers a chain of events leading to cell death. Microcin B17 (MccB17) is a modified peptide bacterial toxin that acts by a similar mode of action, but is unfortunately unsuitable as a therapeutic drug. However, its structure and mechanism could inspire the design of new antibacterial compounds that are needed to circumvent the rise in bacterial resistance to current antibiotics. Here we describe the investigation of the structural features responsible for MccB17 activity and the identification of fragments of the toxin that retain the ability to stabilise the cleavage complex.
Insights
Microcin B17 (MccB17) stabilizes bacterial DNA gyrase, similar to fluoroquinolone antibiotics. Researchers identified MccB17 fragments that retain this DNA cleavage complex stabilization ability for new antibiotic development.
Area of Science:
- Microbiology
- Drug Discovery
- Structural Biology
Background:
- Fluoroquinolones are crucial antibiotics targeting bacterial DNA gyrase.
- Bacterial resistance to antibiotics necessitates novel therapeutic strategies.
- Microcin B17 (MccB17) shares a similar mechanism of action with fluoroquinolones but is not therapeutically viable.
Purpose of the Study:
- To investigate the structural elements of MccB17 responsible for its antibacterial activity.
- To identify MccB17 fragments capable of stabilizing the DNA gyrase-DNA cleavage complex.
- To explore MccB17 as a potential scaffold for developing new antibacterial agents.
Main Methods:
- Structural analysis of Microcin B17.
- Biochemical assays to assess cleavage complex stabilization.
- Identification and characterization of active MccB17 fragments.
Main Results:
- Specific structural features of MccB17 were identified as critical for its activity.
- Certain fragments of MccB17 were found to effectively stabilize the gyrase-DNA cleavage complex.
- These fragments demonstrate potential as starting points for novel antibiotic design.
Conclusions:
- MccB17's mechanism provides insights into DNA gyrase inhibition.
- Fragment-based studies of MccB17 can lead to the development of new antibacterial drugs.
- This research contributes to combating antibiotic resistance by exploring alternative molecular scaffolds.
Related Concept Videos
Bacterial Toxins
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Cytoskeletal Proteins in Bacteria
Gene Regulation in Microbial Communities: Quorum Sensing
